Correlation Between Catalyst Pharmaceuticals and Weyco

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Weyco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Weyco into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Weyco Group, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Weyco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Weyco. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Weyco.

Diversification Opportunities for Catalyst Pharmaceuticals and Weyco

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Catalyst and Weyco is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Weyco Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Weyco Group and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Weyco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Weyco Group has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Weyco go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Weyco

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.15 times more return on investment than Weyco. However, Catalyst Pharmaceuticals is 1.15 times more volatile than Weyco Group. It trades about -0.12 of its potential returns per unit of risk. Weyco Group is currently generating about -0.2 per unit of risk. If you would invest  2,304  in Catalyst Pharmaceuticals on September 13, 2024 and sell it today you would lose (149.50) from holding Catalyst Pharmaceuticals or give up 6.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Weyco Group

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Weyco Group 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Weyco Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Weyco is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Catalyst Pharmaceuticals and Weyco Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Weyco

The main advantage of trading using opposite Catalyst Pharmaceuticals and Weyco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Weyco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Weyco will offset losses from the drop in Weyco's long position.
The idea behind Catalyst Pharmaceuticals and Weyco Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators